As we heard this morning, Dodgers shortstop Hanley Ramirez was held out of the lineup for the second straight game due to irritation in the AC joint in his right shoulder. According to Mark Saxon of ESPN Los Angeles, Dodgers manager Don Mattingly said this afternoon that Ramirez actually got a cortisone shot in his shoulder on Wednesday night and wasn’t even available to pinch-hit today.
Ramirez is expected to sit out again tomorrow at the very least, but the hope is that he’ll be able to avoid a stint on the disabled list.
“Hanley came in today feeling much better, so there’s actually been a lot of success with those shots,” Mattingly said.
As opposed to last season, Ramirez has remained mostly healthy so far this season, appearing in 63 of the Dodgers’ 68 games. While he hasn’t been nearly as productive with the bat as he was last year, he’s still hitting .255 with 10 home runs and an .800 OPS. The 30-year-old is currently in his walk year.
Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.
Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.
The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.
It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.
The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.
Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.